Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 1

Conditions

Visceral Pain 1Rectal Neoplasms 1Pancreatic Neoplasms 1Pain 1Neoplasms 1Agnosia 1

Interventions

Gemcitabine 69Fluorouracil 44pembrolizumab 43Oxaliplatin 42Capecitabine 40Bevacizumab 37Leucovorin 36Irinotecan 31Cisplatin 27Nivolumab 24Paclitaxel 21Cetuximab 21Panitumumab 20130-nm albumin-bound paclitaxel 20Sorafenib 18Albumin-Bound Paclitaxel 18Drug Therapy 15Docetaxel 15Cyclophosphamide 15Radiotherapy 14Blood Specimen Collection 14IFL protocol 12atezolizumab 11Exercise 11Taxes 10budigalimab 9Erlotinib Hydrochloride 9trametinib 8Folfox protocol 8Carboplatin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Transcranial Magnetic Stimulation × Gastrointestinal × Clear all
NCT00324428 2017-03-21

TMS for the Treatment of Pancreatic Cancer Pain

Beth Israel Deaconess Medical Center

Phase NA Completed
3 enrolled
Gastrointestinal

Agnosia, Neoplasms, Pain, Pancreatic Neoplasms, Visceral Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡